پاسیریوتاید (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "پاسیریوتاید" in Persian language version.

refsWebsite

Global rank Persian rank

4^th place

5^th place

9^th place

26^th place

low place

low place

1web.archive.org

1^st place

1^st place

68^th place

179^th place

447^th place

382^nd place

38^th place

109^th place

2^nd place

2^nd place

719^th place

248^th place

doi.org

Mancini, Tatiana; Porcelli, Teresa; Giustina, Andrea (2010). "Treatment of Cushing disease: overview and recent findings". Therapeutics and Clinical Risk Management. 6: 505–16. doi:10.2147/TCRM.S12952. PMC 2963160. PMID 21063461.

europa.eu

ema.europa.eu

«نسخه آرشیو شده» (PDF). بایگانی‌شده از اصلی (PDF) در ۱۴ ژوئن ۲۰۱۸. دریافت‌شده در ۱۰ دسامبر ۲۰۱۷.

fda.gov

accessdata.fda.gov

http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/200677lbl.pdf

medscape.com

"FDA Approves Pasireotide for Cushing's Disease".

nih.gov

pubchem.ncbi.nlm.nih.gov

Pasireotide | C58H66N10O9 - PubChem https://pubchem.ncbi.nlm.nih.gov/compound/Pasireotide

ncbi.nlm.nih.gov

Mancini, Tatiana; Porcelli, Teresa; Giustina, Andrea (2010). "Treatment of Cushing disease: overview and recent findings". Therapeutics and Clinical Risk Management. 6: 505–16. doi:10.2147/TCRM.S12952. PMC 2963160. PMID 21063461.

pubmed.ncbi.nlm.nih.gov

Mancini, Tatiana; Porcelli, Teresa; Giustina, Andrea (2010). "Treatment of Cushing disease: overview and recent findings". Therapeutics and Clinical Risk Management. 6: 505–16. doi:10.2147/TCRM.S12952. PMC 2963160. PMID 21063461.

signifor.com

Signifor® (pasireotide) Official Website for healthcare professionals outside the US http://www.signifor.com/

web.archive.org

«نسخه آرشیو شده» (PDF). بایگانی‌شده از اصلی (PDF) در ۱۴ ژوئن ۲۰۱۸. دریافت‌شده در ۱۰ دسامبر ۲۰۱۷.

yahoo.com

finance.yahoo.com

"Novartis drug Signifor® approved in the EU as the first medication to treat patients with Cushing's disease". Retrieved 2012-07-08.^{^{[پیوند مرده]}}

youtube.com

«Monthly Pasireotide and Cushing's Disease». Rare Disease Report.